{
  "pmcid": "3363360",
  "sha256": "ac20ae5e43d3d0ed409d25abba1b7ec111336ea88730ea09b4efae059259930a",
  "timestamp_utc": "2025-11-09T23:48:09.568175+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 14.015378151260506,
    "reading_ease": 19.51491596638658,
    "word_count": 238
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Mesh Reinforcement in Stapled Left Pancreatectomy"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "single-blinded, parallel-group, randomised controlled trial included patients eligible for left pancreatectomy"
      },
      "Participants": {
        "score": 2,
        "evidence": "Conducted at a large tertiary hospital, this single-blinded, parallel-group, randomised controlled trial included patients eligible for left pancreatectomy."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomised intraoperatively to receive either mesh reinforcement (Seamguard® or Peristrips Dry®) or no mesh reinforcement."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to assess the effectiveness of mesh reinforcement in reducing the incidence of clinically significant pancreatic leaks."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the incidence of clinically significant pancreatic leaks, defined by the ISGPF grading system, over a 6-week period."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was achieved using a computer-generated sequence with allocation concealment."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Patients were blinded to their group allocation."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 100 patients were randomised: 54 to the mesh group and 46 to the control group."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "The analysis was conducted on an intention-to-treat basis."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "ISGPF grade B and C leaks were observed in 1.9% (1/53) of patients in the mesh group compared to 20% (11/45) in the control group (p=0.0007)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No significant adverse events were reported in either group."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "The trial is registered at Clinicaltrials.gov (NCT01359410)."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 21,
    "max_score": 25
  }
}